PATENT CLAIM ANALYSIS

Application Number: 15881409
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "006120"]

Abstract:
Provided herein is technology for neoplasia screening, and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of cancer, in particular, colorectal cancer.

Claim (Index 118):
The composition of  claim 112 , wherein the plurality of different methylated marker DNAs are bisulfate-converted DNAs.

Metadata:
- Claim Count in Document: 324.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15471337', '15841006', '14966938', '15252966', '14669834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6384790257140214
- 35 USC 102 Novelty (BERT): 0.5418039367615395
- Combined Prediction Score: 0.6288115168187731
- Mean Citation Score: 348.420024
- Max Citation Score: 412.8369
- Similarity Product: 264.6828231420816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test